Trials / Recruiting
RecruitingNCT06193577
Effect of Phaseolus Vulgaris L. Dry Extract on the Modulation of Weight and Metabolic Parameters
Single-centre, Prospective, Randomized, Placebo-controlled, Single-blind Clinical Trial to Evaluate the Efficacy of a Food Supplement Based on Phaseolus Vulgaris L. Dry Extract on the Modulation of Weight and Metabolic Parameters
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- IBSA Farmaceutici Italia Srl · Industry
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the efficacy of Phaseolus vulgaris L. dry extract on weight modulation.
Detailed description
Monocentric, prospective, randomized, single-blind clinical trial to evaluate the effects of Phaseolus vulgaris L. dry extract (test) on weight reduction and on metabolic parameters after 12 weeks of supplementation. The efficacy on weight reduction will be evaluated in comparison with the placebo group (control).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Phaseolus Vulgaris L. Dry Extract | Extracts of Phaseolus vulgaris (beans) in association with a balanced diet are known to reduce glycaemia and food intake in rodents and humans thus promoting weight loss. |
| DIETARY_SUPPLEMENT | Placebo | The placebo control does not contain active ingredients. |
Timeline
- Start date
- 2023-11-08
- Primary completion
- 2025-06-30
- Completion
- 2025-06-30
- First posted
- 2024-01-05
- Last updated
- 2025-01-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06193577. Inclusion in this directory is not an endorsement.